Multifunctional quantum dot–polypeptide hybrid nanogel for targeted imaging and drug delivery

Nanoscale ◽  
2014 ◽  
Vol 6 (19) ◽  
pp. 11282-11292 ◽  
Author(s):  
Jie Yang ◽  
Ming-Hao Yao ◽  
Lang Wen ◽  
Ji-Tao Song ◽  
Ming-Zhen Zhang ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Quantum Dot ◽  
Cancer Diagnosis ◽  
Targeted Imaging ◽  
New Class

A new class of multifunctional quantum dot (QD)–polypeptide hybrid nanogel with targeted imaging and drug delivery properties is reported as a nanocarrier for use in cancer diagnosis, imaging, and therapy.

Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics

Nanoscale ◽  
2017 ◽  
Vol 9 (30) ◽  
pp. 10948-10960 ◽  
Author(s):  
Xian-Wu Hua ◽  
Yan-Wen Bao ◽  
Zhan Chen ◽  
Fu-Gen Wu
Keyword(s):  
Drug Delivery ◽  
Quantum Dots ◽  
Quantum Dot ◽  
Carbon Quantum Dots ◽  
Targeted Imaging ◽  
Mitochondrial Targeting ◽  
Carbon Quantum Dot ◽  
Targeting Ability

A novel type of carbon quantum dot with intrinsic mitochondrial-targeting ability was prepared for mitochondria-targeted imaging and drug delivery.

Radiolabeled Peptide Probes for Liver Cancer Imaging

2020 ◽  
Vol 27 (41) ◽  
pp. 6968-6986
Author(s):  
Rui Cao ◽  
Hongguang Liu ◽  
Zhen Cheng
Keyword(s):  
Liver Cancer ◽  
Cancer Diagnosis ◽  
Cancer Imaging ◽  
Growth Factor Receptor ◽  
Targeted Imaging ◽  
Cancer Death ◽  
Binding Properties ◽  
Radiolabeled Peptides ◽  
Epidermal Growth ◽  
Peptide Probes

Liver cancer/Hepatocellular Carcinoma (HCC) is a leading cause of cancer death and represents an important cause of mortality worldwide. Several biomarkers are overexpressed in liver cancer, such as Glypican 3 (GPC3) and Epidermal Growth Factor Receptor (EGFR). These biomarkers play important roles in the progression of tumors and could serve as imaging and therapeutic targets for this disease. Peptides with adequate stability, receptor binding properties, and biokinetic behavior have been intensively studied for liver cancer imaging. A great variety of them have been radiolabeled with clinically relevant radionuclides for liver cancer diagnosis, and many are promising imaging and therapeutic candidates for clinical translation. Herein, we summarize the advancement of radiolabeled peptides for the targeted imaging of liver cancer.

Strategies for Conjugation of Biomolecules to Nanoparticles as Tumor Targeting Agents

2019 ◽  
Vol 25 (37) ◽  
pp. 3917-3926
Author(s):  
Sajjad Molavipordanjani ◽  
Seyed Jalal Hosseinimehr
Keyword(s):  
Drug Delivery ◽  
Iron Oxide ◽  
Medical Imaging ◽  
Cancer Diagnosis ◽  
Carbon Nanoparticles ◽  
Tumor Targeting ◽  
Polymeric Nanoparticles ◽  
Inorganic Nanoparticles ◽  
Active Targeting ◽  
Cancer Diagnosis And Therapy

Combination of nanotechnology, biochemistry, chemistry and biotechnology provides the opportunity to design unique nanoparticles for tumor targeting, drug delivery, medical imaging and biosensing. Nanoparticles conjugated with biomolecules such as antibodies, peptides, vitamins and aptamer can resolve current challenges including low accumulation, internalization and retention at the target site in cancer diagnosis and therapy through active targeting. In this review, we focus on different strategies for conjugation of biomolecules to nanoparticles such as inorganic nanoparticles (iron oxide, gold, silica and carbon nanoparticles), liposomes, lipid and polymeric nanoparticles and their application in tumor targeting.

Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis

2020 ◽  
Vol 20 (11) ◽  
pp. 1288-1299
Author(s):  
Paromita Kundu ◽  
Deepika Singh ◽  
Abhalaxmi Singh ◽  
Sanjeeb K. Sahoo
Keyword(s):  
Drug Delivery ◽  
Side Effects ◽  
Cancer Diagnosis ◽  
Specific Drug ◽  
Novel Therapies ◽  
Future Directions ◽  
Normal Tissues ◽  
Cancer Management ◽  
Single Probe ◽  
Therapy And Diagnosis

The panorama of cancer treatment has taken a considerable leap over the last decade with the advancement in the upcoming novel therapies combined with modern diagnostics. Nanotheranostics is an emerging science that holds tremendous potential as a contrivance by integrating therapy and imaging in a single probe for cancer diagnosis and treatment thus offering the advantage like tumor-specific drug delivery and at the same time reduced side effects to normal tissues. The recent surge in nanomedicine research has also paved the way for multimodal theranostic nanoprobe towards personalized therapy through interaction with a specific biological system. This review presents an overview of the nano theranostics approach in cancer management and a series of different nanomaterials used in theranostics and the possible challenges with future directions.

Application of Nanomaterials in Cancer Diagnosis, Drug Delivery, and Therapy

2020 ◽  
pp. 147-171
Author(s):  
Shahid S. Siddiqui ◽  
Mashael Saeed Al-Qahtani ◽  
Faisal Ahmed Khalil Al Allaf ◽  
Loganathan Sivakumar ◽  
Zeba Kidwai Siddiqui
Keyword(s):  
Drug Delivery ◽  
Cancer Diagnosis

Current Therapies and Future Prospects

2021 ◽  
pp. 306-318
Author(s):  
Muddukrishnaiah K.
Keyword(s):  
Drug Delivery ◽  
Drug Resistance ◽  
Cancer Therapy ◽  
Cancer Diagnosis ◽  
Biomarker Discovery ◽  
Future Prospects ◽  
Cancer Treatments ◽  
Therapeutic Uses ◽  
Current Therapies ◽  
Targeted Drug

Due to drug resistance, lack of cancer cell selectivity, and solubility, conventional cancer treatments lose their therapeutic uses, and as such, new therapeutic agents need to be developed. Nanomaterials and peptides are increasingly being used in the fields of cancer diagnosis, biomarker discovery due to their therapeutic values and novel way of targeting and curing the disease. Synergism among the peptide-conjugated nanoparticles is an exhilarating group of materials, not only sharing the benefits of conventional nanomedicine, but also possessing the unique properties of excellent biocompatibility, biodegradability, versatile sensitivity, specific biological purpose, and synthetic feasibility. These virtues inspired by the scientists and have taken advantage in the peptide-conjugated nano drugs for the accurate delivery of drugs reliably to the site of the lesion. This chapter offers a summary of emerging technologies that have recently been developed in the broad field of peptide-conjugated nanoparticles and offers guidance for targeted drug delivery and cancer therapy.

Sign in / Sign up

Export Citation Format

Share Document